Acquired antiretroviral drug resistance mutations among subtype C Ethiopian patients after a median time of 30 months on ART.

Age: in years; F: Female, M: Male; CD4+ T in cells/mm3; HIV RNA in copies/ml; Before: Before ART (baseline); After: After initiation of ART; Time on ART in months; NRTI (Nucleoside RT inhibitors): 3TC (lamiduvine), ddI (didanosine), d4T (stavudine), FTC (emtricitabine), TDF (tenofovir), ZDV (zidovudine); NNRTI (non-nucleoside RT inhibitors): EFV (efavirenz), ETR (etravirine), NVP (nevirapine); Amino acids: A (alanine), E (glutmatate), G (glucine), K (lysine), L (leucine), M (methionine), N (asparganine), S (serine), V (valine), Y (tyrosine)Acquired antiretroviral drug resistance mutations among subtype C Ethiopian patients after a median time of 30 months on ART.